BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
BeyondSpring
BYSI
$35.8M
| $10.4M | ﹤0.01% |
669,347
+83,659
| +14% | +$1.24M |
|
3227
Bankwell Financial Group
BWFG
$533M
| $10.4M | ﹤0.01% |
359,464
+3,065
| +0.9% | +$87.6K |
|
3228
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.43B
| $10.4M | ﹤0.01% |
+109,250
| New | +$9.47M |
|
3229
Crawford & Co Class A
CRD.A
$669M
| $10.3M | ﹤0.01% |
901,340
+31,451
| +4% | +$343K |
|
|
ESXB
3230
DELISTED
Community Bankers Trust Corporation
ESXB
| $10.3M | ﹤0.01% |
1,164,114
-2,305
| -0.2% | -$20K |
|
3231
Schwab International Equity ETF
SCHF
$68.7B
| $10.3M | ﹤0.01% |
611,946
-77,548
| -11% | -$1.28M |
|
3232
Schwab International Small-Cap Equity ETF
SCHC
$5.65B
| $10.3M | ﹤0.01% |
296,439
-33,301
| -10% | -$1.11M |
|
3233
Mid Penn Bancorp
MPB
$952M
| $10.3M | ﹤0.01% |
356,327
-1,014
| -0.3% | -$26.9K |
|
|
DQ
3234
Daqo New Energy
DQ
$996M
| $10.2M | ﹤0.01% |
1,000,750
+28,640
| +3% | +$244K |
|
3235
Rockwell Medical
RMTI
$28.2M
| $10.2M | ﹤0.01% |
38,130
+3,418
| +10% | +$859K |
|
3236
Quad
QUAD
$525M
| $10.2M | ﹤0.01% |
2,181,062
+17,617
| +0.8% | +$110K |
|
3237
Savara
SVRA
$1.19B
| $10.2M | ﹤0.01% |
2,270,620
-256,063
| -10% | -$308K |
|
3238
Pulse Biosciences
PLSE
$3.02B
| $10.2M | ﹤0.01% |
758,242
+3,466
| +0.5% | +$49.4K |
|
3239
Flexsteel Industries
FLXS
$311M
| $10.2M | ﹤0.01% |
510,005
+10,795
| +2% | +$188K |
|
|
CASI
3240
DELISTED
CASI Pharmaceuticals
CASI
| $10.2M | ﹤0.01% |
328,515
+5,027
| +2% | +$163K |
|
3241
DHI Group
DHX
$173M
| $10.1M | ﹤0.01% |
3,355,641
+66,854
| +2% | +$227K |
|
|
EVBN
3242
DELISTED
Evans Bancorp Inc
EVBN
| $10.1M | ﹤0.01% |
251,472
+6,000
| +2% | +$234K |
|
|
OCFT
3243
DELISTED
OneConnect Financial Technology
OCFT
| $10M | ﹤0.01% |
+100,000
| New | +$9.92M |
|
|
PZN
3244
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $10M | ﹤0.01% |
1,161,035
+17,192
| +2% | +$148K |
|
|
TESS
3245
DELISTED
Tessco Technologies Inc
TESS
| $9.99M | ﹤0.01% |
890,925
-5,872
| -0.7% | -$74.6K |
|
3246
First Bank
FRBA
$454M
| $9.96M | ﹤0.01% |
901,518
+5,794
| +0.6% | +$62.8K |
|
|
LOVE
3247
LoveSac
LOVE
$261M
| $9.95M | ﹤0.01% |
619,720
+37,514
| +6% | +$585K |
|
|
AIU
3248
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
| $9.93M | ﹤0.01% |
11,910
+792
| +7% | +$700K |
|
3249
Hamilton Beach Brands
HBB
$422M
| $9.88M | ﹤0.01% |
517,666
-8,526
| -2% | -$157K |
|
|
PRVB
3250
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $9.79M | ﹤0.01% |
656,931
+173,917
| +36% | +$1.55M |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.